Hjem › Lipoid nefrose › Texas
Lipoid nefrose kliniske forsøg i Texas
4 studier for Lipoid nefrose søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
RekruttererFase 2
Alder 16 til 75 · Alle køn · Opdateret 23. sep. 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
- Clinical Advancement Center, San Antonio
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 3. aug. 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
RekruttererFase 2
Alder 1 til 17 · Alle køn · Opdateret 12. maj 2026 · NCT05003986Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.